Ask your provider about emerging research on GLP-1 benefits for skin health
Nausea Nausea ranks as the single most common side effect across all semaglutide clinical trials
The SELECT trial was even larger, enrolling 17,604 patients with obesity and pre-existing cardiovascular disease but without diabetes
The gel-type texture absorbs quickly into skin without any stickiness
Mom and Dad
Glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Ozempic, Wegovy, Rybelsus), liraglutide (Victoza, Saxenda), and tirzepatide (Zepbound, Mounjaro), among the most transformative pharmacologic advances of the past decade, are now attracting attention for a potential role far removed from their origins in blood glucose regulation and weight management: the prevention of colorectal cancer (CRC)